Price $3.96 |
Market Cap
155.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
1.49
|
P/S
2.17
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
-
|
Op. Cash Flow
-65.7K
|
FCF
-2.0
|
|
Op. Margin
-47.70%
|
Net Margin
-41.10%
|
ROE
-26.00%
|
ROI
-30.10%
|
|
ROA
-11.70%
|
EPS Growth
11.80%
|
Current Ratio
2.9
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Esperion Therapeutics Inc (ESPR) | $38.41 | - | - | 1.04B | Strong Buy |
| Invo Bioscience Inc (IVOB) | $0.32 | - | - | 52.8M | Strong Buy |
| IRIDEX Corporation (IRIX) | $2.63 | - | - | 47.2M | Strong Buy |
| Bausch Health Companies Inc (BHC) | $21.30 | - | - | 8.35B | Strong Buy |
| Lannett Company, Inc. (LCI) | $6.77 | - | - | 258.4M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
